var path='https://www.tickertech.net';
function heading(heading) {
document.write('<p><table border="0" cellspacing="0" cellpadding="0" width="100%">'+
'<tr><td><span class="heading">&#149; '+heading+'</span></td></tr>'+
'<tr height="1" bgcolor="#EFEFEF"><td height="1">'+
'<img src="'+path+'/pics/tpixel.gif" width="1" height="1">'+
'</td></tr></table><p>');
}
function hiLite(imgDocID,imgObjName) {
document.images[imgDocID].src = eval(imgObjName + ".src");	
}
function showStatus(toshow) {
window.status = toshow;
}
function checkChoose() {
if (document.choose.ticker.value == "") {
alert("Please enter symbols before clicking the go button");
return false;
}
else return true;
}
function popJT(url,name){
var xwid = screen.width;
xwid = xwid - 10;
javaticker = window.open(url,name,'width='+xwid+',height=100,resizable=yes,scrollbars=no,toolbar=no,location=no,directories=no,status=yes,menubar=no');
javaticker.opener.name="opener";
//javaticker.moveTo(0,30);
}



	var allow = 0;
	var ref = ""+location;
	if ((ref.indexOf("cryptocurrencieschannel.com") > 0) || (ref.indexOf("cefchannel.com") > 0) || (ref.indexOf("bdcinvestor.com") > 0) || (ref.indexOf("tickertech.com") > 0) || (ref.indexOf("xxxx:") > 0) || (ref.indexOf("javascript:") > 0) || (ref.indexOf("filseclab.com") > 0) || (ref.indexOf("msnscache.com") > 0) || (ref.indexOf("toolbar.google.com") > 0) || (ref.indexOf("etfchannel.com") > 0) || (ref.indexOf("marketnewsvideo.com") > 0) || (ref.indexOf("news.google.com") > 0) || (ref.indexOf("dividendchannel.com") > 0) || (ref.indexOf("www.google.com") > 0) || (ref.indexOf("energystockchannel.com") > 0) || (ref.indexOf("metalschannel.com") > 0) || (ref.indexOf("portfoliochannel.com") > 0) || (ref.indexOf("canadastockchannel.com") > 0) || (ref.indexOf("theonlineinvestor.com") > 0) || (ref.indexOf("investhelp.com") > 0) || (ref.indexOf("preferredstockchannel.com") > 0) || (ref.indexOf("stockoptionschannel.com") > 0) || (ref.indexOf("holdingschannel.com") > 0) || (ref.indexOf("tickertech.net") > 0) || (ref.indexOf("historicalstockprice.com") > 0) || (ref.indexOf("splithistory.com") > 0) || (ref.indexOf("stocksplithistory.com") > 0) || (ref.indexOf("google.c") > 0) || (ref.indexOf("208.71.46.190") > 0) || (ref.indexOf("search.yahoo") > 0) || (ref.indexOf("sharesoutstandinghistory.com") > 0) || (ref.indexOf("marketcaphistory.com") > 0) || (ref.indexOf("ytdreturn.com") > 0) || (ref.indexOf("averageannualreturn.com") > 0) || (ref.indexOf("redinews.com") > 0) || (ref.indexOf("technicalanalysischannel.com") > 0) || (ref.indexOf("stockdma.com") > 0) || (ref.indexOf("stockrsi.com") > 0) || (ref.indexOf("stockmacd.com") > 0) || (ref.indexOf("topdividends.com") > 0) || (ref.indexOf("monthlydividendpayingstocks.com") > 0) || (ref.indexOf("nextearningsdate.com") > 0) || (ref.indexOf("pastearnings.com") > 0) || (ref.indexOf("historicalperatio.com") > 0) || (ref.indexOf("historicalearnings.com") > 0) || (ref.indexOf("webcache.googleusercontent.com") > 0)) { allow = 1; }
	
function ShowTTIPage() {
if (allow) { document.write('<STYLE TYPE="text/css">\n'); }
if (allow) { document.write('<!-- \n'); }
if (allow) { document.write('.TTIptext, .TTIptext SELECT, .TTIptext INPUT {\n'); }
if (allow) { document.write('font-family: Arial,Helvetica,Times\;\n'); }
if (allow) { document.write('font-size:9pt\;\n'); }
if (allow) { document.write('color: #000000 \n'); }
if (allow) { document.write('}\n'); }
if (allow) { document.write('.menu {\n'); }
if (allow) { document.write('font-family: Arial,Helvetica,Times\;\n'); }
if (allow) { document.write('font-size:10pt\;\n'); }
if (allow) { document.write('color: #000000 \n'); }
if (allow) { document.write('}\n'); }
if (allow) { document.write('.menubld {\n'); }
if (allow) { document.write('font-family: Arial,Helvetica,Times\;\n'); }
if (allow) { document.write('font-size:10pt\;\n'); }
if (allow) { document.write('font-weight: bold\;\n'); }
if (allow) { document.write('color: #000000 \n'); }
if (allow) { document.write('}\n'); }
if (allow) { document.write('.heading {\n'); }
if (allow) { document.write('font-family: Arial,Helvetica,Times\;\n'); }
if (allow) { document.write('font-size: 12pt\;\n'); }
if (allow) { document.write('font-weight: bold\;\n'); }
if (allow) { document.write('font-color: black\;\n'); }
if (allow) { document.write('}\n'); }
if (allow) { document.write('a{text-decoration: underline}\n'); }
if (allow) { document.write('a.TTIplink:link{color:#222222}\n'); }
if (allow) { document.write('a.TTIplink:visited{color:#222222}\n'); }
if (allow) { document.write('a.TTIplink:active, a.TTIplink:hover{color:#555555}\n'); }
if (allow) { document.write('a.white:link, a.white:visited{color:#ffffff}\n'); }
if (allow) { document.write('a.white:active, a.white:hover{color:#dddddd}\n'); }
if (allow) { document.write('a.red:link, a.red:visited{color:#a50000}\n'); }
if (allow) { document.write('a.red:active, a.red:hover{color:#ff0000}\n'); }
if (allow) { document.write('-->\n'); }
if (allow) { document.write('</STYLE>\n'); }
if (allow) { document.write('<div name="ptnews" id="ptnews" style="width: 420px"></div>\n'); }
if (allow) { document.write('<table border="0" cellspacing="0" cellpadding="2" width="420">\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">4/26 - 8:30 AM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="https://www.dividendchannel.com/quotes/?a=news&ticker=a&w=&story=202404PZONE69106630" class="TTIplink">HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">4/5 - 4:30 AM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="https://www.dividendchannel.com/quotes/?a=news&ticker=a&w=&story=202404PZONE59085137" class="TTIplink">HUTCHMED Highlights Data to be Presented at AACR Congress 2024</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">4/2 - 1:00 AM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="https://www.dividendchannel.com/quotes/?a=news&ticker=a&w=&story=202404PZONE29082564" class="TTIplink">HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">3/27 - 8:00 PM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="https://www.dividendchannel.com/quotes/?a=news&ticker=a&w=&story=202403PZONE89080228" class="TTIplink">HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Nave or Previously Treated Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">3/21 - 8:00 PM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="https://www.dividendchannel.com/quotes/?a=news&ticker=a&w=&story=202403PZONE29067333" class="TTIplink">HUTCHMED Initiates Registration Stage of the ESLIM-02 Phase II/III Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">2/28 - 6:30 AM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="https://www.dividendchannel.com/quotes/?a=news&ticker=a&w=&story=202402PZONE89054886" class="TTIplink">HUTCHMED Reports 2023 Full Year Results and Provides Business Updates</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">2/6 - 7:00 PM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="https://www.dividendchannel.com/quotes/?a=news&ticker=a&w=&story=202402PZONE79033145" class="TTIplink">HUTCHMED Highlights Presentation of Phase III Data on Fruquintinib in Second-Line Gastric Cancer at ASCO Plenary Series Session</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">2/2 - 3:30 AM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="https://www.dividendchannel.com/quotes/?a=news&ticker=a&w=&story=202402PZONE29030975" class="TTIplink">HUTCHMED Announces that Inmagene Exercises Option to License Two Drug Candidates as Part of Strategic Partnership</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">2/1 - 3:30 AM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="https://www.dividendchannel.com/quotes/?a=news&ticker=a&w=&story=202402PZONE19030286" class="TTIplink">HUTCHMED to Announce 2023 Final Results</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">1/29 - 11:54 PM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="https://www.dividendchannel.com/quotes/?a=news&ticker=a&w=&story=202401PZONE09028215" class="TTIplink">HUTCHMED Receives ELUNATE (fruquintinib) Marketing Approval in Hong Kong for Treatment of Metastatic Colorectal Cancer</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">1/10 - 7:00 PM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="https://www.dividendchannel.com/quotes/?a=news&ticker=a&w=&story=202401PZONE19015747" class="TTIplink">HUTCHMED Announces NDA Acceptance in China for Sovleplenib for the Treatment of Primary Immune Thrombocytopenia with Priority Review Status</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr height="3"><td height="3"><img src="https://www.tickertech.net/pics/tpixel.gif" width="1" height="3" alt=""></td></tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td colspan="2"></td></form>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('</table>\n'); }
if (!allow) { document.write(''+ ''+
'	<h1>Access Denied</h1>'+
'	<h2><font color=red>Please Read This Important Message</font></h2>'+
'	If you are a paying TickerTech.com client and your account was not set up to include the configuration'+
'	received, please email <a href="mailto:support@tickertech.com" class="meta">support@tickertech.com</a>,'+
'	or call us at 1-866-515-2082 to verify your account settings.'+
'	'+
'	<br><br>'+
'	'+
'	<img src="https://www.tickertech.net/pics/caution.gif" width=16 height=16 alt="Note!"> If you reached this page'+
'	after attempting to place a TickerTech.com product onto your web page, go no further;  you must sign up as a'+
'	paying client.  For pricing information please visit our <a href="http://www.tickertech.com/products/">products page</a>, email '+
' 	<a href="mailto:services@tickertech.com">services@tickertech.com</a>, or give us a call at 1-866-515-2082.'+
' 	'+
' 	<br><br>'+
' 	'+
' 	<a href="http://www.tickertech.com/" class="meta">TickerTech.com home</a><br>'+
' 	<a href="http://www.tickertech.com/products/" class="meta">TickerTech.com products</a>'+
' 	<BR>'+
' 	'+
''); }

}